Source briefing
Effect of a digitally augmented general health promotion intervention on abstinence from health-risk behaviors among emergency department discharge patients: A randomized controlled trial
by Ho Cheung William Li, Wei Xia, Joanna Yeung, Laurie Long Kwan Ho, Tan Ankie Cheung, Kai Yeung Cheung, Yiu Cheung Chan, Wai Yee Chan, Chin Wai Lui, Hong Chen Background Noncommunicable diseases (NCDs) are the leading global…
Read →
Source briefing
Multimodal protective and susceptibility clusters in paediatric atopic dermatitis: A machine learning-based, data-driven observational study
by Damir Zhakparov, Nonhlanhla Lunjani, Marco Schmid, Kathleen Moriarty, Damian Roquero, Anita Dreher, Jeannette I. Heldstab-Kast, Kari C. Nadeau, Cezmi Akdis, Michael Levin, Carol Hlela, Milena Sokolowska, Liam O’Mahony, Katja Baerenfaller Background Atopic dermatitis (AD) is a chronic…
Read →Source briefing
More evidence that mass shootings are suicidal acts
New research finds national peaks for suicides, gun rampages take place within days of each other in summer
Read →Source briefing
When the sea steals homes and jobs
Along West Africa’s Gulf of Guinea, Salata Institute research is helping communities and governments weigh excruciating choices about what to protect, how to adapt, and when to retreat
Read →Source briefing
Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of authorisation: 23/03/2015, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of authorisation: 23/03/2015, Revision: 26, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 41, Status: Authorised
Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 41, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Rezolsta, darunavir,cobicistat, Date of authorisation: 19/11/2014, Revision: 20, Status: Authorised
Human medicines European public assessment report (EPAR): Rezolsta, darunavir,cobicistat, Date of authorisation: 19/11/2014, Revision: 20, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Revision: 5, Status: Authorised
Read →Source briefing
EMA/FVE information session for veterinary students: the importance of pharmacovigilance, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 October 2026, 14:30 (CEST) to 13 October 2026, 16:00 (CEST)
EMA/FVE information session for veterinary students: the importance of pharmacovigilance, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 October 2026, 14:30 (CEST) to 13 October 2026, 16:00 (CEST)
Read →Source briefing
Police Tapes Show Malta Businessman Acquitted of Journalist's Murder Said He Initially Approved the Plot
Police interrogation recordings released by the Times of Malta show businessman Yorgen Fenech admitted to initially greenlighting the 2017 assassination of journalist Daphne Caruana Galizia. He said he then retracted his approval. Fenech was acquitted last week after…
Read →